Media Centre - IARC NEWS
|Latest data show a global increase of 13% in childhood cancer incidence over two decades|
An international study coordinated by the International Agency for Research on Cancer (IARC) and published today in The Lancet Oncology shows that in 2001–2010, childhood cancer was 13% more common than in the 1980s, reaching an annual incidence rate of 140 per million children aged 0–14 years worldwide.
Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, Hesseling P, Shin HY, Stiller CA, and the IICC-3 contributors.
International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. Published online 11 April 2017.
Read article , IARC Press Release 251
|IARC Monographs Volume 118: Evaluation of welding, welding fumes, and some related chemicals|
A Working Group of 17 scientists from 10 countries met at the International Agency for Research on Cancer (IARC) on 21–28 March 2017 to evaluate the carcinogenicity of welding, molybdenum trioxide, and indium tin oxide. A summary of the evaluations has now been published in The Lancet Oncology. The detailed assessments will be published as Volume 118 of the IARC Monographs.
Guha N, Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Bouvard V, et al.
Carcinogenicity of welding, molybdenum trioxide, and indium tin oxide
Lancet Oncol, Published online 10 April 2017;
|Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas|
Human papillomavirus (HPV) infection is an emerging risk factor associated with head and neck cancer. A new study led by the Epigenetics Group at the International Agency for Research on Cancer (IARC) identified a novel epigenetic signature of HPV infection in head and neck squamous cell carcinomas (HNSCCs). This signature, which is independent of the anatomical site, was shown to be a better predictor of survival compared with HPV status determined by viral gene expression, and thus could be leveraged for improved prediction of survival in HNSCCs.
Degli Esposti D, Sklias A, Lima SC, Beghelli-de la Forest Divonne S, Cahais V, Fernandez-Jimenez N, et al.
Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas
Genome Medicine. Published online 5 April 2017
|IARC Monographs Meetings - Volume 121: Styrene, Styrene-7,8-oxide, and Quinoline|
IARC Monographs Volume 121: Styrene, Styrene-7,8-oxide, and Quinoline
20-27 March 2018
See more information
|IARC Monographs Meetings - Volume 118: Welding, Welding Fumes, and Some Related Chemicals|
IARC Monographs Volume 118: Welding, Welding Fumes, and Some Related Chemicals
21-28 March 2017
See more information
|Launch of World Indigenous Cancer Conference (WICC) Network|
The International Agency for Research on Cancer (IARC) is proud to be a partner in the WICC Network, which is hosted by Menzies School of Health Research, Australia. The WICC Network is dedicated to improving cancer outcomes for Indigenous peoples around the world. It was established to continue research collaboration after the World Indigenous Cancer Conference (WICC), which was held in Brisbane, Australia, in 2016.
|Glyphosate not classified as a carcinogen by ECHA|
The International Agency for Research on Cancer (IARC) is aware that the Committee for Risk Assessment of the European Chemicals Agency (ECHA) has concluded that the available scientific evidence did not meet the criteria of the “Classification, Labelling and Packaging” (CLP) Regulation required to classify glyphosate as a carcinogen or as genotoxic.
The international experts composing the IARC Monograph Working Group, which evaluated glyphosate in March 2015, concluded that glyphosate is “probably carcinogenic to humans” based on the publicly available scientific evidence on epidemiology, animal carcinogenicity, and carcinogenic mechanisms, using the methodology described in detail in the IARC Monographs preamble.
The IARC evaluation of glyphosate is not affected by the ECHA review. IARC does not comment on the expertise, methodology, or conclusions of other national or international committees.
Read more , Q&A on Glyphosate
|IARC Handbooks of Cancer Prevention Meetings - Volume 17 - Reminder: Deadline for call for experts: 14 March 2017|
IARC Handbooks of Cancer Prevention
Volume 17: Colorectal cancer screening
14-21 November 2017
IARC, Lyon, France
|DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility|
A new study led by the International Agency for Research on Cancer (IARC) evaluates the link between the DNA methylation-based marker of ageing, known as the “epigenetic clock”, and breast cancer risk. The study, based on the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, a large prospective study conducted in 23 centres across 10 European countries, shows that an accelerated epigenetic clock is associated with susceptibility to postmenopausal breast cancer.
Ambatipudi S, Horvath S, Perrier F, Cuenin C, Hernandez-Vargas H, Le Calvez-Kelm F, et al.
DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility
Eur J Cancer, Published online 1 March 2017
|Energy balance and obesity: what are the main drivers?|
The International Agency for Research on Cancer (IARC) convened a Working Group of international experts in December 2015 to review the evidence regarding energy balance and obesity, with a focus on low- and middle-income countries. A summary of the topics addressed and the conclusions and recommendations of the Working Group has been published in Cancer Causes & Control.
Romieu I, Dossus L, Barquera S, Blottière HM, Franks PW, Gunter M, et al.; IARC Working Group on Energy Balance and Obesity
Energy balance and obesity: what are the main drivers?
Cancer Causes Control. Published online 17 February 2017
|IARC Junior Investigator Awards 2017|
The International Agency for Research on Cancer (IARC) is pleased to announce the recipients of the IARC Junior Investigator Awards for 2017.
|IARC Postdoctoral Opportunities - Section of Genetics/Genetic Epidemiology Group|
A postdoctoral opportunity is immediately available within the Genetic Epidemiology Group to work on multidisciplinary cancer studies. Successful candidates should have a strong background in cancer genomics and/or epidemiology and/or biostatistics, as well as a good command of English.
|Release of latest data on incidence of childhood cancer|
The International Agency for Research on Cancer (IARC) is releasing the latest data on the incidence of childhood cancer across the world to mark International Childhood Cancer Day. The results, which are part of the third volume of the International Incidence of Childhood Cancer (IICC) project, are based on collaboration of more than 300 high-quality registries in 82 countries, departments, and territories on five continents. Tabulated data on more than 770 000 neoplasms diagnosed in patients younger than 20 years are now accessible online, with statistics presented for the diagnostic groups relevant to childhood cancer.
Visit the website , Read more
|IARC researchers part of team awarded Grand Challenge grant|
The International Agency for Research on Cancer (IARC) is proud to announce that IARC researchers are part of a team that has been awarded a grant of up to £20 million as part of the Grand Challenge, facilitated by Cancer Research UK. The research project, "Mutographs of Cancer: Discovering the causes of cancer through mutational signatures", is a joint initiative that aims to better define what causes DNA damage and how it leads to cancer. The project is a response to Grand Challenge 3: "Discover how unusual patterns of mutation are induced by different cancer-causing events".
|Implementation of cancer screening in the European Union (2017)|
The International Agency for Research on Cancer (IARC) is pleased to announce the publication of Cancer Screening in the European Union (2017): Report on the Implementation of the Council Recommendation on Cancer Screening. This is the second report on the status of implementation of cancer screening programmes in the European Union since the recommendation from the European Council in 2003. The report was prepared by IARC in collaboration with the Piedmont Reference Center for Epidemiology and Cancer Prevention (CPO Piemonte), Italy, and the Cancer Society of Finland (CSF), Mass Screening Registry, Finland.
View the report , Read the EC press release
|World Cancer Day 2017|
Every year on World Cancer Day (4 February), the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) support the Union for International Cancer Control (UICC) in promoting ways to reduce the global burden of cancer. On 3 February 2017, IARC is hosting the 4th IARC Cancer and Society Lecture, featuring Karin Holm , who will present a talk entitled "Patient Power for Better Research: I Can, We Can".
4th IARC Cancer and Society lecture
Friday 3 February 2017 at 11:00 am
Read more , Watch video
|Affordable vaccines key to scale up HPV vaccination and prevent thousands of avoidable cervical cancers|
Every year, cervical cancer kills more than 250 000 women, and 85% of these deaths occur in low- and middle-income countries. Cervical cancer is the fourth most common cancer in women worldwide, but most of these deaths could be prevented with adequate prevention measures, such as vaccination of girls against human papillomavirus (HPV) and screening programmes to detect and treat precancerous lesions.
Read IARC Press Release 250 , Watch videos
|Launch of Exposome-Explorer website|
The International Agency for Research on Cancer (IARC) is pleased to announce the launch of the Exposome-Explorer website. Exposome-Explorer is a manually curated database of biomarkers of exposure to dietary and environmental factors. The database was developed at IARC in collaboration with the University of Alberta, Canada. The website should be particularly useful for researchers wishing to select panels of biomarkers that can be used in biomonitoring studies or in exposome-wide association studies, thereby allowing them to better understand the etiology of chronic diseases.
Visit the website
|IARC Monographs Volume 112: Some Organophosphate Insecticides and Herbicides|
The International Agency for Research on Cancer (IARC) is pleased to announce that the IARC Monographs volume on Some Organophosphate Insecticides and Herbicides is now available online. The volume includes monographs on diazinon, glyphosate, malathion, parathion, and tetrachlorvinphos.
Visit the Volume 112 webpage
|IARC Postdoctoral Opportunities - Section of Cancer Surveillance|
A postdoctoral opportunity is immediately available within the Section of Cancer Surveillance to participate in the SURVMARK-2 project (A Comprehensive Approach to International Cancer Survival Benchmarking).
Deadline: 12 February 2017
|WHO Classification of Head and Neck Tumours|
The WHO Classification of Head and Neck Tumours is the ninth volume in the 4th Edition of the WHO series on histological and genetic typing of human tumours. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies evaluating response to therapy and clinical outcome.
WHO Classification of Head and Neck Tumours
WHO/IARC Classification of Tumours, 4th Edition, Volume 9
Edited by El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ
|Launch of the SABC website|
The International Agency for Research on Cancer (IARC) is pleased to announce the launch of the South Africa Breast Cancer (SABC) study website. The SABC study is a population-based case–control study set up at the Baragwanath Hospital in Soweto, South Africa, to study the etiology of breast cancer in black South African women. The study is very important because it is among the first to study specific factors, including lifestyle and dietary habits, in the black South African population that may be associated with specific subtypes of breast cancer. The aim of the study is to advance the prevention and management of breast cancer in black women in South Africa through a better understanding of the molecular, pathological, and risk factor patterns.
|Dominique Hornez (1954–2017)|
The International Agency for Research on Cancer (IARC) is saddened by the passing of Dominique Hornez, a long-time IARC staff member, who died on Sunday 8 January 2017 in Lyon. Our deepest sympathy is with his son, Florent.
|IARC scientist receives Rosalind E. Franklin Award|
The International Agency for Research on Cancer (IARC) is pleased to announce that Dr Silvia Franceschi, Special Advisor on Noncommunicable Diseases and Head of the Infections and Cancer Epidemiology Group in the IARC Section of Infections, is the 2017 recipient of the Rosalind E. Franklin Award, presented today by the United States National Cancer Institute. The prize honours the commitment of women in cancer research and is given in tribute to Dr Franklin, who played a critical role in the discovery of the DNA double helix. On the occasion of the award, Dr Franceschi is presenting a lecture on "Global burden of cancer attributable to infections (with focus on HPV)".
Read more , View photos
|IARC Postdoctoral Opportunities - Section of Mechanisms of Carcinogenesis/Epigenetics Group|
Two postdoctoral opportunities: "Postdoctoral opportunity in epigenetic mechanisms and cancer development" and "Postdoctoral opportunity in epigenetics and breast cancer" are immediately available within the Epigenetics Group to study epigenetics and cancer.
Deadline: 31 January 2017
|IARC Monographs Volume 110: Some Chemicals Used as Solvents and in Polymer Manufacture|
The International Agency for Research on Cancer (IARC) is pleased to announce that the IARC Monographs volume on Some Chemicals Used as Solvents and in Polymer Manufacture is now available online.
Visit the Volume 110 webpage